从疗效和毒副作用等方面对新一代抗癌铂络合物的临床研究结果进行了简要的综述． 新一代抗癌铂络合物主要是：奥沙利铂（ｏｘａｌｉｐｌａｔｉｎ），诺贝铂（ｌｏｂａｐｌａｔｉｎ），欧玛铂（ｏｒｍａｐｌａｔｉｎ）， ２５４－Ｓ， ＴＲＫ７１０和ＤＷＡ２１１４Ｒ．综合各项研究成果，作者认为奥沙利铂（Ｏｘａｌｉｐｌａｔｉｎ）与顺铂和 碳铂相比具有不同的抗癌谱和非交叉抗性等特殊抗癌效果，很有可能成为新一代抗癌药． The results of clinical studies on a new generation of anticancer platinum complexes are briefly reviewed in terms of curative effects and toxic side effects. The new generation of anti-cancer platinum complexes are mainly: oxaliplatin, lobaplatin, ormaplatin, 254-S, TRK710 and DWA2114R. Based on the results of the research, the authors consider that Oxaliplatin has different anticancer effects such as anti-cancer spectrum and non-crossover resistance compared with cisplatin and carboplatin, and is likely to become a new generation of anticancer drug.